Lataa...
Siplizumab selectively depletes effector memory T-cells and promotes a relative expansion of alloreactive regulatory T-cells in vitro
Siplizumab, a humanized anti-CD2 monoclonal antibody, has been used in conditioning regimens for hematopoietic cell transplantation and tolerance induction with combined kidney-bone marrow transplantation. Siplizumab-based tolerance induction regimens deplete T cells globally while enriching regulat...
Tallennettuna:
| Julkaisussa: | Am J Transplant |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940533/ https://ncbi.nlm.nih.gov/pubmed/31319439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15533 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|